HOME >> MEDICINE >> NEWS
Leading international osteoporosis experts to present at world's largest osteoporosis congress

Eleven of the world's leading osteoporosis experts will present plenary lectures at the 2006 IOF World Congress on Osteoporosis (IOF WCO) in Toronto, Canada.

"We have selected these speakers for their ability to present the latest science in a format that will be useful for the thousands of health care professionals who will attend the IOF WCO," noted Professor Ren Rizzoli, Chairman, IOF Committee of Scientific Advisors and Chairman, IOF World Congress on Osteoporosis 2006 Scientific Committee.

IOF World Congress on Osteoporosis plenary lectures and presenters:

  • Determinants of Fracture: Load versus Strength Dr. Mary L. Bouxsein, USA
  • WHO Criteria for Indications to Treatment Prof. John A. Kanis, UK
  • Osteocytes and Mechanical Load Prof. Brendon Noble, UK
  • Wnt as a Target for Therapy Prof. Roland Baron, USA
  • IGF and Bone Health Prof. Clifford J. Rosen, USA
  • Paleolithic Lifestyle and Bone Dr. S. Boyd Eaton, USA
  • Immune System and Bone Health Prof. Matthew T. Gillespie, Australia
  • Cardiovascular Diseases and Osteoporosis: From Epidemiology to Biology Dr. Lorenz C. Hofbauer, Germany
  • SARMs, SERMs, SGRM Dr. Donald McDonnell, USA
  • Androgen & Estrogen in Bone Prof. Claes Ohlsson, Sweden
  • Rationale for Choosing Anabolic or Antiresorptive Treatment Dr. Socrates E. Papapoulos, The Netherlands

Themes to be covered in thirty-five oral presentations and more than six hundred and eighty poster presentations include nutrition, smoking and exercise and osteoporosis; osteoporosis diagnosis, treatment, epidemiology and health economics issues; pregnancy, infancy and osteoporosis; osteoporosis in men, and stone age and space age bones what they have in common. These were selected from a record number of 720 abstracts.

Through seventy-four "Meet the Expert" sessions, international osteoporosis experts will cover key
'"/>

Contact: Janice Blondeau
IOFnews@osteofound.org
41-229-940-106
International Osteoporosis Foundation
22-Mar-2006


Page: 1 2

Related medicine news :

1. Leading prevention researchers meeting in Washington, D.C., May 30-June 1, 2007
2. Leading advocates express support for microbicide research, despite disappointing trial results
3. Leading European experts in magnetic resonance for animals
4. Leading healthcare authorities to address safety and effectiveness
5. Leading hepatology textbook edited by SLU researchers
6. Leading groups offer NIH direct links to journals to make research access easy for public
7. Leading immunosuppressant CellCept significantly extends the lifespan of transplanted kidneys
8. Leading pediatricians group recommends infants sleep in cribs, not parents beds
9. Leading genomic technology expert to present Dickson Prize Lecture at Pitt
10. Leading experts discuss how to protect premature infants against RSV, a potentially dangerous virus
11. Leading sleep expert at Wake Forest to speak at NIH Consensus Conference

Post Your Comments:
(Date:10/31/2014)... HealthDay Reporter THURSDAY, Oct. 30, 2014 ... transplantation is nothing new. The first kidney transplant took ... 1963 and the first human heart transplant in 1967. By ... entire face. One major organ still eludes the transplant ... of U.S. scientists has its way, that dream may become ...
(Date:10/31/2014)... News) -- The number of medical malpractice payments in ... to a new study. And compensation payment amounts ... or declined in recent years, researchers report online Oct. ... Association . "For many physicians, the prospect of ... of modern clinical practice," researchers, led by Michelle Mello, ...
(Date:10/31/2014)... WASHINGTON, DC (October 31, 2014) — A new ... (Milken Institute SPH) at the George Washington University ... for pregnant women who are enrolled in Covered ... which includes the Comprehensive Perinatal Services Program (CPSP). ... the nation,s most successful programs ever developed for ...
(Date:10/30/2014)... day provide new treatments for injuries and damage to ... Cartilage, for example, is a hard material that caps ... smoothly. UC Davis biomedical engineers, exploring ways to toughen ... the body, report new developments this week in the ... . , "The problem with engineered tissue is that ...
(Date:10/30/2014)... group at the DFG Research Center for Regenerative Therapies ... (CRTD) demonstrated for the first time the in vitro ... dimensions from mouse embryonic stem cells. Correct spatial organization ... dorsal/ventral axis was observed., This study has been published ... Reports " on 30.10.2014 ., For many years Elly ...
Breaking Medicine News(10 mins):Health News:Scientists Set Their Sights on First Whole-Eye Transplant 2Health News:Scientists Set Their Sights on First Whole-Eye Transplant 3Health News:Fewer Malpractice Claims Paid in U.S. 2Health News:Report examines health care challenges for pregnant women enrolled in covered California 2Health News:Making lab-grown tissues stronger 2Health News:Reconstruction of a patterned piece of spinal cord in 3-D culture 2
(Date:10/30/2014)... 2014   ViaDerma, Inc. (OTCQB: VDRM), ... products to market, has recently released a revolutionary ... a topical liquid tetracycline-based antibiotic that uses a ... oral medication active ingredients into topical drugs. The ... antibiotic to help prevent skin infection in minor ...
(Date:10/30/2014)... , Oct. 30, 2014 China Biologic Products, ... leading fully integrated plasma-based biopharmaceutical company in ... to release third quarter 2014 financial results on Wednesday, ... The Company,s management will hold a conference call ... 2014, which is 8:30 p.m., Beijing Time on November ...
(Date:10/30/2014)... October 30, 2014 , ... LGG contribuye a adquirir tolerancia a la proteína ... la proteína de la leche de la vaca (APLV) ... infancia. Hasta ahora, la APLV se trataba eliminando ... ha demostrado que es posible adquirir tolerancia oral ...
Breaking Medicine Technology:ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3China Biologic to Report Third Quarter 2014 Financial Results 2Según expertos reunidos en el Simposio Allergy Day 2Según expertos reunidos en el Simposio Allergy Day 3
Cached News: